News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Asahi Kasei Pharma (AHKSY.PK) And Eisai Company, Ltd. (ESALY.PK) In Sales Promotion Agreement For Eril In China



4/5/2006 2:37:47 PM

Tokyo, Apr 3, 2006 (JCN) - Asahi Kasei Pharma Corporation and Eisai Co., Ltd. announced on March 31 that AKP and Eisai China Inc., a subsidiary of Eisai, signed an agreement on March 28 giving Eisai China exclusive rights to promote injectable formulations of AKP's vasodilator Eril (fasudil hydrochloride) in China.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES